Drug Shortage Report for SHINGRIX
Report ID | 59145 |
Drug Identification Number | 02468425 |
Brand name | SHINGRIX |
Common or Proper name | Herpes Zoster vaccine |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | VARICELLA-ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN |
Strength(s) | 50MCG |
Dosage form(s) | SUSPENSION |
Route of administration | INTRAMUSCULAR |
Packaging size | 10's |
ATC code | J07BK |
ATC description | |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2018-08-24 |
Estimated end date | |
Actual end date | 2020-06-17 |
Shortage status | Resolved |
Updated date | 2020-06-18 |
Company comments | High demand for the drug coupled with the variable timing of supply shipments. Re-supply is ongoing with current inventory on allocation. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.